Zhaoyan New Drug
PulseAugur coverage of Zhaoyan New Drug — every cluster mentioning Zhaoyan New Drug across labs, papers, and developer communities, ranked by signal.
-
Institutions trade tech stocks; Eli Lilly acquires Atai Beckley; DeepSeek eyes IPO
On July 16th, institutional investors showed activity across 54 stocks, with net buying in 20 and net selling in 34. Huatian Technology, Maige Mite, and Haesken Huijgensdr were among the top net buys, while Montage Tech…
-
Rongsheng Petrochemical subsidiary plans 19.6B yuan refinery upgrade
Rongsheng Petrochemical's subsidiary, Zhejiang Petrochemical, plans to invest 19.6 billion yuan in a refinery integration project. This upgrade aims to increase the depth of product processing and boost the output of hi…
-
Zhaoyan New Drug forecasts massive profit jump; China to launch active ETFs
Zhaoyan New Drug anticipates a significant surge in net profit for the first half of the year, projecting an increase of 884.9% to 1377.4%. This growth is attributed to rising market prices for biological assets and int…